Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Dow Chemical and Bend Research are developing and commercializing new materials for spray-dried dispersions that address technology gaps in manufacturability and delivery.

Collaboration Targets Advances in Spray-Dried Dispersion Solutions for Poorly Soluble Drugs

Matthieu Egloff, product director with ATMI LifeSciences, discusses the need for larger, special reactors that can provide the necessary conditions for the production of fragile cells on a larger scale.

New Reactor Technology Enables Larger Scale Manufacture of Fragile Cells

The growth in biologics drugs and vaccines is leading to greater demand for prefilled syringes, which provide greater safety and convenience for healthcare workers and patients.

Technology and Adoption of Prefilled Syringes Advance

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Roche and BioLamina have entered into a research and development agreement to jointly develop new cell culture systems for various applications, including stem cell research. The collaboration will assess laminin-based in-vitro cell culture matrices that can offer physiological microenvironments for living cells.

Roche and BioLamina Collaborate on Novel Cell Culture Systems

Amy Ritter was Scientific Editor, BioPharm International.

Mylan announced that it has signed an agreement to acquire the generic injectables unit Agila Specialties from Strides Arcolab for $1.6 billion in cash.

Mylan Acquires Generic Injectables Unit From Strides Arcolab

Simon Chalk is director of the BioPhorum Operations Group, simon@biophorum.com.

Companies risk drowning in alphabet soup if the latest three-letter acronym improvement strategy isn't clearly linked to business strategy.

Relevance Regained

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Applying quality-by-design and process analytical technology facilitates process understanding and control of various operations in lyophilization.

Advances in PAT for Parenteral Drug Manufacturing

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Vaccine development is benefiting from manufacturing advances and support for global health.

Vaccine Innovation Yields New Products and Processes

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Growth is seen in outsourcing of insect- and plant-cell-based bioproduction expression systems.

Outsourcing Nontraditional Protein Expression Systems

Recent advances in equipment design and operation in spraying, drying, and mixing can improve the tablet-coating process.